BIMI Announces Results of 2023 Annual General Meeting of Stockholders
New York, Jan. 03, 2024 (GLOBE NEWSWIRE) — BIMI Holdings Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), previously known as […]
Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia
FOSTER CITY, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical […]
Atea Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
BOSTON, Jan. 03, 2024 (GLOBE NEWSWIRE) — Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company engaged in the […]
Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
PRINCETON, N.J., Jan. 03, 2024 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that Bradley Campbell, President and Chief […]
Athira Pharma Completes Enrollment of Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease
Topline data from LIFT-AD on track for second half of 2024 Previously reported independent, unblinded interim analysis supports trial continuation […]
InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice President and General Manager of North America
Appointment brings more than 30 years of medical technology general management and commercial leadership experience to the InspireMD team Reports […]
BioCardia Biotherapeutic Delivery and Morph Access Innovations Business Development Update for Shareholders
SUNNYVALE, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) — BioCardia, Inc. (Nasdaq: BCDA), a developer of cellular and cell-derived therapeutics for the […]
Voyager Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
LEXINGTON, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic […]
SEALSQ To Launch SEALCOIN, a digital token and advanced cryptocurrency protocol, at the Davos Space IoT and Cybersecurity Event on January 17, 2024
Tortola, British Virgin Islands, Jan. 03, 2024 (GLOBE NEWSWIRE) — January 3, 2024: SEALSQ Corp (“SEALSQ” or “Company”) (NASDAQ: LAES), […]
Editas Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced […]
